MorphoSys AG

It was Groundhog Day on 2 February. That week, any pharmaceutical groundhogs would have emerged from their burrows, glanced at the shadows of tariffs, a global trade war and weak Chinese demand and sc

As the business development directors of big pharma companies flock to the annual J.P. Morgan Healthcare conference in San Francisco, important meetings will happen away from the conference ballrooms

Pharma Breaks Bread With Trump And RFK Jr But Will They Butt Heads? Donald Trump’s second term as US president does not begin until 20 January but pharma executives spent much of last year wondering w

As Novartis management headed to London to meet investors and analysts after upping mid-term sales guidance, CEO Vas Narasimhan has been trumpeting the Swiss major’s pipeline and recent product launch